Structure and properties of pharmacologically active polymers
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Although the concept of using pharmacologically active macromolecular compounds as drugs is still regarded with much skepticism for both theoretical and practical reasons, interest in this field has grown in recent years because of the opportunity to take advantage of the specific properties of polymeric materials. For low molecular weight drugs, changes in structure often lead to a loss of specific activity. On the other hand, the properties of macromolecular drugs depend on the structure of the polymer used and this can be varied over a wide range by the incorporation of comonomer units, by the application of polymer‐analogous reactions, or by related structural changes. A new model is presented for pharmacologically active polymers which incorporates the possibility for continuous variation in (a) solubility and toxicity, (b) fixation and removal of active material, and (c) body distribution. Using the new model as a guide, examples of the synthesis and study of the biological activity of various macromolecular drugs are presented in order to emphasize the importance of this cooperative effort between polymer research and therapeutic problems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The drug-polymer conjugates were introduced in the early work by Helmut Ringsdorf in 1970s to improve drug solubility, toxicity, and body biodistribution, which was followed by extensive studies on the development of drug-polymer conjugates [143, 144].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [144]
Citations
Cites
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Chang, T. M. S. (1964) · Science · doi:10.1126/science.146.3643.524 · Cited by 1,011
Lysosomes in Biology and Pathology
Lagunoff, D. (1974) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1974.03230160059035 · Cited by 887
AN EXAMINATION OF THE CYTOTOXIC EFFECTS OF SILICA ON MACROPHAGES
Allison, A. C., Harington, J. S., & Birbeck, M. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.2.141 · Cited by 871
FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGE
Boneu, B., Abbal, M., Plante, J., & Bierme, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92650-1 · Cited by 716
de Duve, C. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470715314.ch1 · Cited by 473
DRUG-CARRIER POTENTIAL OF LIPOSOMES IN CANCER CHEMOTHERAPY
Gregoriadis, G., Swain, C. P., Wills, E. J., & Tavill, A. S. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90682-5 · Cited by 401
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Ryser, H. J.-P. (1968) · Science · doi:10.1126/science.159.3813.390 · Cited by 288
Research works printed but not linked: 20
- Lee H., 1971, Handbook for Surgery and Artificial Organs
- Kabaiwanow W., 1972, Plaste Kaut., 19, 886
- Wessel W., 1971, Arzeim. Forsch., 21, 1468
- Ryser H. J. P., 1970, Proc. Fourth Int. Cong. Pharm., 3, 96
- 1965, Silikose Forsch., 6, 213
- Ferruti P., 1966, Med. Lav., 57, 481
- V.Hofmann dissertation University of Mainz 1975.
- Burger A., 1970, Medicinal Chemistry, 1185
- Donaruma L. G., 1974, Prog. Polym. Sci., 4, 18
- G.Franzmann dissertation University of Mainz 1975.
- H.Morawetzet al. in press.
- Ringsdorf H., 1967, Strahlentherapie, 132, 627
- Busch H., 1961, Cancer Res., 21, 271
- H.Ritter dissertation University of Mainz 1975.
- M.Przybylski dissertation University of Mainz 1975.
- Jacob S. W., 1971, Dimethylsulfoxide
- V.Hofmann H.Ringsdorf andG.Muacevic Makromol. Chem. in press.
- Jacques P. J., 1966, Rev. Quest. Sci., 27, 99
- Jacques P. J., 1969, Lysosomes in Biology and Pathology, 395
- Szekerke M., 1972, Neoplasma, 19, 211
Cited by
Items 801–900 of 1,000
Ouchi, T., & Chikashita, H. (1983) · Journal of Macromolecular Science Part A - Chemistry · doi:10.1080/00222338308060781 · Cited by 6
Lee, S., Choi, W., Ha, C., & Cho, W. (1999) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/(sici)1099-0518(19990715)37:14<2619::aid-pola36>3.0.co;2-7 · Cited by 6
Nguyen, K. V., Jung, L., Coupin, G., & Poindron, P. (1986) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.1986.080240213 · Cited by 6
Prodrugs and Drug Delivery Systems
Silverman, R. B., & Holladay, M. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-382030-3.00009-x · Cited by 5
An Economical and Scalable Preparation of Poly(Ethylene Glycol) Methyl Ether Amine, M.W. 5,000
Banasik, B., Nadala, C., & Samadpour, M. (2018) · Organic Preparations and Procedures International · doi:10.1080/00304948.2018.1405333 · Cited by 5
Peptide-Targeted Polymer Cancerostatics
Böhmová, E., & Pola, R. (2016) · Physiological Research · doi:10.33549/physiolres.933418 · Cited by 5
Ritt, N., Berger, S., Wagner, E., & Zentel, R. (2020) · ACS Applied Polymer Materials · doi:10.1021/acsapm.0c00818 · Cited by 5
Amin, H., Khan, A., Makeen, H. A., Rashid, H., Amin, I., Masoodi, M. H., Khan, R., Arafah, A. M., & Rehman, M. U. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824109-7.00020-0 · Cited by 5
Synthesis and Operating Optimization of the PEG Conjugate via CuAAC in scCO2
López, S., Gracia, I., García, M. T., Rodríguez, J. F., & Ramos, M. J. (2021) · ACS Omega · doi:10.1021/acsomega.0c05466 · Cited by 5
“The next step was to optimize the operating conditions using a factorial design 2 3 , where the most signi fi cant in fl uence of the process variables was observed.”
Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin
Alavi, N., Rezaei, M., Maghami, P., Fanipakdel, A., & Avan, A. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220120115140 · Cited by 5
Drug Delivery Systems: 3B. Role of Polymers in Drug Delivery
Ranade, V. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03448.x · Cited by 5
“This polymer has a number of advantages for controlled release systems, including: (1) it is an elastomer with good mechanical properties; (2) it is highly permeable to hydrophobic solutes; (3) it is nontoxic; (4) it is molded into a wide variety of shapes and is polymerized with simple techniques; and (5) its permeab…”
BackgroundMethodInfluentialPolymeric Antitumour Agents on a Molecular and on a Cellular Level?
Gros, L., & Ringsdorf, H. (1983) · Springer eBooks · doi:10.1007/978-1-4615-7643-3_2 · Cited by 5
Self-citationCytotoxicity of ruthenocene-containing β-diketones.
Kemp, K. C., Nell, M. J., van Rensburg, C. E. J., & Swarts, J. C. (2012) · PubMed · Cited by 5
Khazaei, A., Zolfigol, M. A., & Abedian, N. (2001) · Cited by 5
Advances in Nanomedicine for Head and Neck Cancer
Panikkanvalappil, S. R., El‐Sayed, M. A., & El‐Sayed, I. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-27601-4_51 · Cited by 5
Ardana, A., Whittaker, A. K., & Thurecht, K. J. (2017) · Macromolecular Research · doi:10.1007/s13233-017-5111-z · Cited by 6
Veronese, F. M., & Pasut, G. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00159-0 · Cited by 5
Ram, M., Babaei, M., Zolfaghari, R., Abnous, K., Taghdisi, S. M., Ramezani, M., & Alibolandi, M. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c01064 · Cited by 5
From Self‐Organization to Tumor‐Immune Therapy: How Things Started and How They Evolved
Barz, M., Nuhn, L., Hörpel, G., & Zentel, R. (2022) · Macromolecular Rapid Communications · doi:10.1002/marc.202100829 · Cited by 5
Shakesheff, K. M. (2011) · Wiley eBooks · doi:10.1002/9783527635818.ch15 · Cited by 5
Block Copolymer Micelles for Drug Delivery in Nanoscience
Bae, Y., Cabral, H., & Kataoka, K. (2006) · Wiley eBooks · doi:10.1002/9783527610570.ch4 · Cited by 5
Polymer Therapeutics as Nano‐Sized Medicines for Tissue Regeneration and Repair
Armiñán, A., Sepúlveda, P., & Vicent, M. J. (2014) · Wiley eBooks · doi:10.1002/9781118356692.ch8 · Cited by 5
Zecheru, T., Rotariu, T., Rusen, E., Mărculescu, B., Miculescu, F., Alexandrescu, L., Antoniac, I., & Stancu, I. (2010) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-010-4129-y · Cited by 5
“The first rational model for pharmacologically active polymers was proposed by Ringsdorf in 1975 [8], who recognized the immense potential of polymeric prodrugs.”
BackgroundProtected polyvinylamine fragments capable of liberation under mild conditions
Carpino, L. A., Hettrich, G., & Ringsdorf, H. (1978) · Die Makromolekulare Chemie · doi:10.1002/macp.1978.021791207 · Cited by 5
Self-citationSmart Nanoassemblies and Nanoparticles
Ebara, M., Kotsuchibashi, Y., Uto, K., Aoyagi, T., Kim, Y., Narain, R., Idota, N., & Hoffman, J. M. (2014) · NIMS monographs · doi:10.1007/978-4-431-54400-5_3 · Cited by 6
Pharmaceutical applications of functionalized polymers
Petrak, K. (1989) · Reactive Polymers · doi:10.1016/0923-1137(89)90030-4 · Cited by 5
Bhattarai, P. R., Vance, D., Hatefi, A., & Khaw, B. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1271421 · Cited by 5
Radical polymerization and antibacterial activity of copolymers based on N-1-adamantylmaleimide
Chern, Y. (1996) · Polymer Bulletin · doi:10.1007/bf00296008 · Cited by 5
Enzyme and Nonenzyme Hydrolyses of End Ester Group in Polyethylene Glycol Esters
Ouchi, T., & Azuma, T. (1984) · Journal of Macromolecular Science Part A - Chemistry · doi:10.1080/00222338408056574 · Cited by 5
Fibrinolytic action of an enzyme preparation covalently bound with modified thrombin
Максименко, А. В., Rusetskiĭ, A. N., & Torchilin, V. P. (1987) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf00840131 · Cited by 5
Polymeric Derivatives of Chloramphenicol and Their Antibacterial Properties
Shiraishi, K., & Sugiyama, K. (1988) · Journal of Macromolecular Science Part A - Chemistry · doi:10.1080/00222338808052137 · Cited by 5
Sawada, H., Ikeno, K., & Kawase, T. (2000) · European Polymer Journal · doi:10.1016/s0014-3057(99)00266-9 · Cited by 5
Syntheses and biological activities of 5′-O-methacryloyl-3′-azido-3′-deoxythymidine and its polymers
Choi, W., Lee, N., Lee, Y.-W., Ha, C., & Cho, W. (1997) · Polymer Bulletin · doi:10.1007/s002890050183 · Cited by 5
Syntheses and antitumor and anti‐aids activities of polymers containing pyrimidine derivative
Choi, W., Lee, N., Lee, Y., Ha, C., & Cho, W. (1997) · Macromolecular Symposia · doi:10.1002/masy.19971180180 · Cited by 5
Drug targeting to tumors using HPMA copolymers
Lammers, T. (2009) · Utrecht University Repository (Utrecht University) · Cited by 6
Targeting with Synthetic Polymers: A Realistic Goal
Lloyd, J. B. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5185-6_8 · Cited by 5
Chitosan conjugates in precision medicine: from synthesis to their role in advanced drug delivery
Khan, O., Bhawale, R., Vasave, R., & Mehra, N. K. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151010 · Cited by 4
Acid-Responsive Drug Delivery Systems: Advances and Perspectives
Zhong, H., Zong, Y., Du, H., Wang, J., Qu, S., Gong, N., Yu, B., Cheng, Q., & Guo, S. (2026) · Polymer science & technology. · doi:10.1021/polymscitech.6c00051 · Cited by 5
“57 The development of PDCs has been span for several decades since Ringsdorf 58 proposed the concept of pharmacologically active polymers composed of typical ternary structures.”
Responsive polymer-biomacromolecule conjugates for drug delivery
Cassano, R., Mellace, S., & Trombino, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101997-9.00020-5 · Cited by 4
Toward Intracellular Bioconjugation Using Transition-Metal-Free Techniques
Govindarajan, A., & Vasuki, G. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00173 · Cited by 4
Polymer based Drug Delivery Systems- benchtop to Bedside Transition
Ray, P. (2021) · Journal of Drugs Addiction & Therapeutics · doi:10.47363/jdat/2021(2)113 · Cited by 4
Karakuş, G. (2022) · Hittite Journal of Science & Engineering · doi:10.17350/hjse19030000284 · Cited by 4
Karakuş, G., & Ataş, M. (2023) · ChemistrySelect · doi:10.1002/slct.202301866 · Cited by 4
Sardar, M. S., Kashinath, K. P., Gupta, U., Roy, S., & Kaity, S. (2024) · Polymers for Advanced Technologies · doi:10.1002/pat.6461 · Cited by 4
Polymer–Drug Conjugate in Focal Drug Delivery
Swami, R., Kumar, D. K., Khan, W., Sistla, R., & Shastri, N. R. (2013) · Advances in delivery science and technology · doi:10.1007/978-1-4614-9434-8_5 · Cited by 4
“ta rg et in g – [ 1 14 ]”
BackgroundInfluentialPEG: a useful technology in anticancer therapy
Mero, A., Pasut, G., & Veronese, F. M. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8679-5_15 · Cited by 4
“In the mid-1970s Ringsdorf proposed for the first time the idea of covalently attached chemotherapeutic agents to a water-soluble polymer in order to increase the solubility and the stability of hydrophobic drugs and, possibly, to enhance the tumor specificity by the addition of a targeting residue [ 5 ].”
BackgroundWinne, K. D., Seymour, L. W., & Schacht, E. H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.09.006 · Cited by 4
Can, H. K., Parvizikhosroshahi, S., & Uluışık, E. C. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.980506 · Cited by 4
“…therapeutic activity of many drugs; therefore, novel, biologically active, anhydride-containing polymers are expected to show considerably high biological activities because of the anionic character of the polymers formed after their hydrolysis in the medium (Ringsdorf 1975, Ottenbrite 1982).”
BackgroundLangner, Е. H. G., Swarts, J. C., Tuchscherer, A., Lang, H., Joone, G., & van Rensburg, C. E. J. (2012) · PubMed · Cited by 4
Zhang, P., Xu, J., Gao, S. E., & Li, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-42863-7.00012-8 · Cited by 5
Mukaya, H. E., van Zyl, R. L., Vuuren, N. J. V., & Mbianda, X. Y. (2017) · International Journal of Polymeric Materials · doi:10.1080/00914037.2017.1342248 · Cited by 4
“Polymeric conjugates, pioneered by Ringsdorf [11], have several advantages over non-polymeric drugs; due to their high molecular mass, the polymeric conjugates are not excreted renally, and this leads to a lengthening of their circulation time [12].”
BackgroundTunable Biopolymeric Drug Carrier Nanovehicles and Their Safety
Suner, S. S., Ari, B., Demirci, Ş., & Şahiner, N. (2020) · Springer eBooks · doi:10.1007/978-981-15-6255-6_16 · Cited by 4
Organic nanocarriers for targeted delivery of anticancer agents
Dahiya, S., & Dahiya, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00010-9 · Cited by 4
Chemische Ansätze für synthetische Wirkstofftransportsysteme für systemische Anwendungen
Braatz, D., Cherri, M., Tully, M., Dimde, M., Ma, G., Mohammadifar, E., Reisbeck, F., Ahmadi, V., Schirner, M., & Haag, R. (2022) · Angewandte Chemie · doi:10.1002/ange.202203942 · Cited by 4
Gostev, A. I., Sivtsov, E. V., & Grigoriev, D. V. (2022) · Polymer Science Series B · doi:10.1134/s1560090422700622 · Cited by 4
Polymeric Drugs Based on Random Copolymers with Antimitotic Activity
López-Donaire, M. L., Parra, J., Fernández‐Gutiérrez, M., Vázquez‐Lasa, B., & Román, J. S. (2010) · Biomacromolecules · doi:10.1021/bm100672c · Cited by 4
Can, H. K., Gürpınar, Ö. A., Onur, M. A., Rzaev, Z. M. O., & Güner, A. (2009) · Journal of Applied Polymer Science · doi:10.1002/app.31291 · Cited by 4
Polymers in Drug Delivery: Concepts, Developments and Potential
Chen, R. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-6010-3_1 · Cited by 5
Polymeric Drug Conjugates by Controlled Radical Polymerization
Kim, S.-H., Nguyen, T. H. T., & Maynard, H. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-055294-1.00266-x · Cited by 4
Semi-crystalline fluorinated polymers
Giannetti, E. (2001) · Polymer International · doi:10.1002/1097-0126(200101)50:1<7::aid-pi641>3.0.co;2-7 · Cited by 145
Delivering the vaccination mail
Stayton, P. S. (2003) · Trends in biotechnology · doi:10.1016/j.tibtech.2003.09.004 · Cited by 4
NANOTECHNOLOGY AND CANCER - AN OVERVIEW
Subbiah, B., & Devi, B. P. (2010) · International Journal of Pharma and Bio Sciences · Cited by 5
Targeting - Cancer — Small Molecules
de Groot, V. (2007) · Springer eBooks · doi:10.1007/978-0-387-49785-3_13 · Cited by 4
Overview of Synthetic and Modified Natural Bioactive Polymers
Gebelein, C. G., Carraher, C. E., & Foster, V. R. (1988) · Springer eBooks · doi:10.1007/978-1-4684-5610-3_1 · Cited by 4
Macromolecular Prodrugs Containing Organoiron-Based Compounds in Cancer Research: A Review
Mukaya, H. E., & Mbianda, X. Y. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666191107142926 · Cited by 4
Huang, J., Chen, S., Tan, L., & Wang, H. (1998) · Science China Chemistry · doi:10.1007/bf02875557 · Cited by 4
“As shown by scheme 4, 11.5 g of polymer ( 4 ) was dissolved into 80 mL mixed solvents of acetic acid and methanol ( v/ v = 1 : 1 ) under stirring and acidolized 24 h, and then precipitated with ether.”
BackgroundMethodInfluentialSynthesis and controlled release behaviour of esters from amylose and 1‐naphthylacetyl chloride
Sánchez‐Chaves, M., & Arranz, F. (1990) · Die Makromolekulare Chemie · doi:10.1002/macp.1990.021910704 · Cited by 4
Synthesis and Hydrolysis of Polymers Having Anesthetic or Amantadine Residues in Sidechains
Sugiyama, K. (1986) · Journal of Macromolecular Science Part A - Chemistry · doi:10.1080/00222338608069485 · Cited by 4
Biological activities of new poly(N 1-adamantylmaleimide) and poly(N-1-diamantylmaleimide)
Wang, J.-J., & Chern, Y. (1996) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856296x00075 · Cited by 4
Modified Polysaccharides with Potential Anti-Arrhythmic Activity
Schacht, E. H., Ruys, L., Vermeersch, J., & Goethals, E. J. (1983) · Springer eBooks · doi:10.1007/978-1-4613-3748-5_22 · Cited by 4
Alkylation of poly(n‐vinylpyrrolidone‐co‐vinylamine) with esters of phosphorous acids
Trendafilova‐Gercheva, D., Vassileva, V., Georgieva, M., Troev, K. D., & Панарин, Е. Ф. (1991) · Die Angewandte Makromolekulare Chemie · doi:10.1002/apmc.1991.051870112 · Cited by 4
Drug Targeting with Polymeric Micelle Drug Carriers
Yokoyama, M. (2002) · doi:10.1201/9781420041187-14 · Cited by 4
Peptide-Based Therapeutics and Drug Delivery Systems
Mahto, A. K., Kumari, S., Akbar, S., Paroha, S., Sahoo, P. K., Kumar, A., & Dewangan, R. P. (2023) · Springer eBooks · doi:10.1007/978-981-19-7952-1_7 · Cited by 3
Yang, J., Yang, Z., Wang, H., Chang, Y., Xu, J., & Zhang, X. (2024) · Angewandte Chemie · doi:10.1002/ange.202402291 · Cited by 3
Bionanoconjugates in Neurodegeneration: Peptide–Nanoparticle Alliances for Next-Generation Therapies
Ranjitha, V. R., Kumar, P. S. A., & Kaalappa, P. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03941-0 · Cited by 4
“The concept of a polymer ‒ drug conjugate was first proposed by Helmet Ringsdorf in 1975 [15], marking a significant advancement in targeted drug delivery systems.”
Passi, C., Neu, T., Schneider‐Daum, N., Lehr, C., Schneider, M., & Lee, S. (2026) · ChemMedChem · doi:10.1002/cmdc.202500810 · Cited by 3
Akiyoshi, K. (2002) · CRC Press eBooks · doi:10.1201/9781420041187.sec1 · Cited by 3
Hydrophilic CO-Releasing Material of PEGlyated Ruthenium Carbonyl Complex
Zhang, X., Guo, N., Yang, S., Khan, H., & Zhang, W. (2022) · Materials · doi:10.3390/ma15103597 · Cited by 3
“Ringsdorf [23], and the subsequent precedents of PEGlyated therapeutic agents by A.”
BackgroundLiu, C., Hern, F. Y., Shakil, A., Temburnikar, K. W., Chambon, P., Liptrott, N. J., McDonald, T. O., Neary, M., Flexner, C. W., Owen, A., et al. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb02268d · Cited by 3
Polymeric innovations in drug delivery: Enhancing therapeutic efficacy
Gangadi, J. R., Kokkula, P. K., & Kannadasan, M. (2024) · International Journal of Pharmaceutical Chemistry and Analysis · doi:10.18231/j.ijpca.2024.041 · Cited by 3
Olędzka, E., Dyrka, M., Sobczak, M., Zgadzaj, A., & Nałęcz‐Jawecki, G. (2016) · Journal of Macromolecular Science Part A · doi:10.1080/10601325.2015.1132915 · Cited by 3
Nanoparticles hybridization to engineer biomaterials for drug delivery
Mohammadi, M. R., Sun, W., Inayathullah, M., & Rajadas, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100963-5.00008-2 · Cited by 3
Development of nanocarriers for innovative antimalarial combination strategies
Balogun, M. O., Akolade, J. O., & Balogun, A. O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821100-7.00003-0 · Cited by 3
Role of Nanotechnology Against Malaria: Current Perspectives and Strategies
Gupta, S., Umeyor, C. E., & Patravale, V. B. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-39020-3_7 · Cited by 3
Ethylcellulose- An Amazing Polymer For Anticancer Formulations
Mittal, V., Kriplani, P., & Guarve, K. (2023) · Current Applied Polymer Science · doi:10.2174/0124522716273253231129104511 · Cited by 3
Ligand‐Assisted Vascular Targeting of Polymer Therapeutics
Eldar‐Boock, A., Polyak, D., & Satchi‐Fainaro, R. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch20 · Cited by 3
Fante, C., & Greco, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9164-4_7 · Cited by 5
HPMA-Anticancer Drug Conjugates
Rihova, B., Hovorka, O., Kovar, L., Kovar, M., Mrkvan, T., Šírová, M., Šubr, V., & Ulbrich, K. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0507-9_3 · Cited by 3
Lee, S. M., Ha, C., & Cho, W. J. (2000) · Molecular crystals and liquid crystals science technology. Section A, Molecular crystals and liquid crystals/Molecular crystals and liquid crystals science and technology. Section A, Molecular crystals and liquid crystals · doi:10.1080/10587250008023621 · Cited by 3
A Time Travel Journey Through Cancer Therapies
Cravo, A. S., & Mrsny, R. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_1 · Cited by 3
Kang, N., Lee, S., Maeda, M., Ha, C., & Cho, W. (2002) · Polymer International · doi:10.1002/pi.786 · Cited by 3
Karakuş, G. (2015) · MARMARA PHARMACEUTCAL JOURNAL · doi:10.12991/mpj.20151910458 · Cited by 3
Chemical conjugation of dexamethasone to a polyaspartamide and in vitro evaluation studies
Cavallaro, G., Maniscalco, L., Giammona, G., Civiale, C., Mazzone, M. G., & Enea, V. (2004) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(04)50066-7 · Cited by 3
Lee, J. S., Jung, Y. J., Doh, M. J., & Kim, Y. M. (2000) · Journal of Bioactive and Compatible Polymers · doi:10.1106/8jem-pxvd-wyfc-kwdc · Cited by 3
Polymers for Drugs, Drug-Protein Conjugates, and Gene Delivery
Duncan, R., Ringsdorf, H., & Satchi‐Fainaro, R. (2007) · Cited by 3
Self-citationPolymer conjugates in biomedical applications
Martinez-Robinson, K. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821344-5.00008-4 · Cited by 3
Margret, A. (2016) · IGI Global eBooks · doi:10.4018/978-1-5225-1762-7.ch052 · Cited by 3
Design and Synthesis of a New Class of Self-Cross-Linked Polymer Nanogels
Jiwpanich, S. (2011) · Scholarworks (University of Massachusetts Amherst) · doi:10.7275/2175157 · Cited by 3
Antiinflammatory activities of polymers of o‐methacryloyloxybenzoic acid
Grimová, J., & Hrabák, F. (1978) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820120407 · Cited by 3
Darstellung und Polymerisation von Salicylsäurevinylestern
Heublein, G., Heublein, B., Heyroth, B., & Brendel, E. (1979) · Zeitschrift für Chemie · doi:10.1002/zfch.19790190313 · Cited by 3
Metadata
- Authors
- Ringsdorf, H.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Ringsdorf, Helmut
- Venue
- Journal of Polymer Science: Polymer Symposia
- Publisher
- Wiley
- Published
- 1975-01
- Volume
- 51
- Issue
- 1
- Pages
- 135-153
- ISSN
- 0360-8905 (ISSN-L)
- 1936-0959
- OpenAlex
- W2098279377
- Cited by
- 1,094
- References
- 63
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 34 · 2023: 35 · 2022: 30 · 2021: 35 · 2020: 50 · 2019: 36 · 2018: 29 · 2017: 46 · 2016: 45 · 2015: 47 · 2014: 55 · 2013: 43 · 2012: 48
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Polymer Science Polymer Symposia (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- macromolecular drugs, comonomer incorporation, polymer-analogous reactions, solubility, toxicity, body distribution, polymer synthesis, biological activity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.